Sinovac says its coronavirus vaccine candidate appears safe for elderly in early trials
Chinese firm Sinovac Biotech Ltd. said on Monday its coronavirus vaccine candidate appeared to be safe for older people, according to preliminary results from an early to mid-stage trial, while the immune responses triggered by the vaccine were slightly weaker than for younger adults.